Association Study of 167 Candidate Genes for Schizophrenia Selected by a Multi-Domain Evidence-Based Prioritization Algorithm and Neurodevelopmental Hypothesis

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Zhao, Zhongming ^a   Webb, Bradley T ^b,c   Jia, Peilin ^a   Bigdeli, T Bernard ^b   Maher, Brion S ^d   van den Oord, Edwin ^b,c   Bergen, Sarah E ^e,f   Amdur, Richard L ^g   O'Neill, Francis A ^h   Walsh, Dermot ⁱ   Thiselton, Dawn L ^b   Chen, Xiangning ^b,c,j   Pato, Carlos N ^l   Riley, Brien P ^b,c,j   Kendler, Kenneth S ^b,c,j   Fanous, Ayman H ^b,g,j,k,l  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

ⁱ HEALTH RESEARCH BOARD   (Ireland)

^j VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CNTN4 GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; NERVOUS SYSTEM DEVELOPMENT; PRKCE GENE; PRKG1 GENE; PROTEIN PROTEIN INTERACTION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84880812070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067776     Document Type: Article

References (51)

1. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, et al. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
2. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, et al. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757.
3. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, et al. (2009) Common variants conferring risk of schizophrenia. Nature 460: 744-747.
4. Kirov G, Rujescu D, Ingason A, Collier DA, O'Donovan MC, et al. (2009) Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull 35: 851-854.
5. Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, et al. (2011) Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43: 969-976.
6. Webb BT, Sullivan PF, Skelly T, van den Oord EJ, (2008) Model-based gene selection shows engrailed 1 is associated with antipsychotic response. Pharmacogenet Genomics 18: 751-759.
7. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT, (2006) Neurobiology of schizophrenia. Neuron 52: 139-153.
8. Kendler KS, O'Neill FA, Burke J, Murphy B, Duke F, et al. (1996) Irish study on high-density schizophrenia families: field methods and power to detect linkage. Am J Med Genet 67: 179-190.
9. Thiselton DL, Vladimirov VI, Kuo PH, McClay J, Wormley B, et al. (2008) AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol Psychiatry 63: 449-457.
10. Holmans PA, Riley B, Pulver AE, Owen MJ, Wildenauer DB, et al. (2009) Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms. Mol Psychiatry 14: 786-795.
11. Storey JD, (2003) The positive false discovery rate: A Bayesian interpretation and the q-value. Annals Stat 31: 2013-2035.
12. Riley B, Kuo PH, Maher BS, Fanous AH, Sun J, et al. (2009) The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Schizophr Res 115: 245-253.
13. Guo AY, Sun J, Riley BP, Thiselton DL, Kendler KS, et al. (2009) The dystrobrevin-binding protein 1 gene: features and networks. Mol Psychiatry 14: 18-29.
14. Munafo MR, Thiselton DL, Clark TG, Flint J, (2006) Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry 11: 539-546.
15. Li D, Collier DA, He L, (2006) Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 15: 1995-2002.
16. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human Protein Reference Database-2009 update. Nucleic Acids Res 37: D767-772.
17. Breitkreutz BJ, Stark C, Reguly T, Boucher L, Breitkreutz A, et al. (2008) The BioGRID Interaction Database: 2008 update. Nucleic Acids Res 36: D637-640.
18. Stark C, Breitkreutz BJ, Chatr-Aryamontri A, Boucher L, Oughtred R, et al. (2011) The BioGRID Interaction Database: 2011 update. Nucleic Acids Res 39: D698-704.
19. Bader GD, Betel D, Hogue CW, (2003) BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res 31: 248-250.
20. Batagelj V, Mrvar A (2003) Pajek - Analysis and Visualization of Large Networks. In: Mutzel P, Mutzel P, editors. Graph Drawing Software (Mathematics and Visualization). Berlin: Springer. pp. 77-103.
21. Miyamoto S, LaMantia AS, Duncan GE, Sullivan P, Gilmore JH, et al. (2003) Recent advances in the neurobiology of schizophrenia. Mol Interv 3: 27-39.
22. Sun J, Jia P, Fanous AH, Evd Oord, Chen X, et al. (2010) Schizophrenia gene networks and pathways and their applications for novel candidate gene selection. PLoS ONE 5: e11351.
23. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, et al. (2005) Efficiency and power in genetic association studies. Nat Genet 37: 1217-1223.
24. O'Connell JR, Weeks DE, (1998) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63: 259-266.
25. Martin ER, Monks SA, Warren LL, Kaplan NL, (2000) A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 67: 146-154.
26. Dudbridge F, (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25: 115-121.
27. Purcell SM, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
28. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
29. de Bakker PI, Ferreira MA, Jia X, Neale BM, Raychaudhuri S, et al. (2008) Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet 17: R122-128.
30. Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, et al. (2008) Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry 13: 570-584.
31. Howie BN, Donnelly P, Marchini J, (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5: e1000529.
32. Marchini J, Howie B, Myers S, McVean G, Donnelly P, (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39: 906-913.
33. North BV, Curtis D, Sham PC, (2002) A note on the calculation of empirical P values from Monte Carlo procedures. Am J Hum Genet 71: 439-441.
34. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43: 969-976.
35. Fernandez T, Morgan T, Davis N, Klin A, Morris A, et al. (2008) Disruption of Contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am J Hum Genet 82: 1385.
36. Roohi J, Montagna C, Tegay DH, Palmer LE, DeVincent C, et al. (2009) Disruption of contactin 4 in three subjects with autism spectrum disorder. J Med Genet 46: 176-182.
37. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, et al. (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459: 569-573.
38. Burbach JP, van der Zwaag B, (2009) Contact in the genetics of autism and schizophrenia. Trends Neurosci 32: 69-72.
39. Campbell DB, Lange LA, Skelly T, Lieberman J, Levitt P, et al. (2008) Association of RGS2 and RGS5 variants with schizophrenia symptom severity. Schizophr Res 101: 67-75.
40. Green EK, Grozeva D, Moskvina V, Hamshere ML, Jones IR, et al. (2010) Variation at the GABAA receptor gene, Rho 1 (GABRR1) associated with susceptibility to bipolar schizoaffective disorder. Am J Med Genet B Neuropsychiatr Genet 153B: 1347-1349.
41. Kwon IK, Wang R, Thangaraju M, Shuang H, Liu K, et al. (2010) PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4. Oncogene 29: 3423-3434.
42. Alimohamad H, Rajakumar N, Seah YH, Rushlow W, (2005) Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol Psychiatry 57: 533-542.
43. Park YS, Hur EM, Choi BH, Kwak E, Jun DJ, et al. (2006) Involvement of protein kinase C-epsilon in activity-dependent potentiation of large dense-core vesicle exocytosis in chromaffin cells. J Neurosci 26: 8999-9005.
44. Green MJ, Cairns MJ, Wu J, Dragovic M, Jablensky A, et al. (2012) Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia. Mol Psychiatry Epub ahead of print June 26, 2012.
45. Greenwood TA, Light GA, Swerdlow NR, Radant AD, Braff DL, (2012) Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PLoS ONE 7: e29630.
46. Sun J, Jia P, Fanous AH, Webb BT, van den Oord EJ, et al. (2009) A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case. Bioinformatics 25: 2595-2602.
47. Rodd ZA, Bertsch BA, Strother WN, Le-Niculescu H, Balaraman Y, et al. (2007) Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach. Pharmacogenomics J 7: 222-256.
48. Jia P, Ewers JM, Zhao Z, (2011) Prioritization of epilepsy associated candidate genes by convergent analysis. PLoS ONE 6: e17162.
49. Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, et al. (2012) Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry 17: 887-905.
50. Guo AY, Sun J, Jia P, Zhao Z, (2010) A novel microRNA and transcription factor mediated regulatory network in schizophrenia. BMC Syst Biol 4: 10.
51. Sun J, Wan C, Jia P, Fanous AH, Kendler KS, et al. (2011) Application of systems biology approach identifies and validates GRB2 as a risk gene for schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Schizophr Res 125: 201-208.